Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 2565520)

Published in Tex Heart Inst J on January 01, 2008

Authors

Puja K Mehta1, Leo Simpson, Eva K Lee, Teresa A Lyle, Michael E McConnell, Wendy M Book

Author Affiliations

1: Division of Cardiology, Department of Internal Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Articles cited by this

A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60

Bosentan therapy for pulmonary arterial hypertension. N Engl J Med (2002) 11.18

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet (2001) 6.88

Treatment of pulmonary arterial hypertension. N Engl J Med (2004) 6.88

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation (2006) 3.05

Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64

Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation (2003) 2.22

The Eisenmenger syndrome in adults. Ann Intern Med (1998) 1.98

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation (2000) 1.97

Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest (2002) 1.94

Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest (2003) 1.71

Initial experience with bosentan therapy in patients with the Eisenmenger syndrome. Am J Cardiol (2004) 1.55

Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease. Heart (2005) 1.48

Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation (1999) 1.47

Endothelin antagonists. Lancet (1999) 1.20

Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine. Obstet Gynecol (2004) 1.13

Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter study of bosentan therapy. Am Heart J (2005) 1.09

State-of-the-Art lecture. Role of endothelin-1 in hypertension. Hypertension (1999) 1.02

Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med (2001) 0.98

Effect of long term oxygen treatment at home in children with pulmonary vascular disease. Br Heart J (1986) 0.92

Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol (2005) 0.91

Pulmonary arterial hypertension in congenital heart disease. Cardiol Clin (2002) 0.82

Drug therapy for pulmonary arterial hypertension: what's on the menu today? Chest (2003) 0.78

Lung transplantation for primary pulmonary hypertension and Eisenmenger's syndrome. J Cardiovasc Nurs (2005) 0.77

Articles by these authors

Systems biology of vaccination for seasonal influenza in humans. Nat Immunol (2011) 6.09

Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96

Initial experience with bosentan therapy in patients with the Eisenmenger syndrome. Am J Cardiol (2004) 1.55

DNA motifs associated with aberrant CpG island methylation. Genomics (2006) 1.40

Management of warfarin in children with heart disease. Pediatr Cardiol (2011) 1.38

A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. Cancer Res (2009) 1.15

Incidental diagnosis of interrupted aortic arch in a 72-year-old man. Tex Heart Inst J (2009) 1.14

Assessing the continuum of event-based biosurveillance through an operational lens. Biosecur Bioterror (2012) 1.13

High-resolution mapping of h1 linker histone variants in embryonic stem cells. PLoS Genet (2013) 1.11

Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis. Physiol Genomics (2013) 1.00

Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol (2013) 0.98

Effects of pulmonary valve replacement on QRS duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction. Am J Cardiol (2005) 0.96

Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol (2007) 0.96

Caseous calcification of the mitral annulus. Tex Heart Inst J (2008) 0.95

Right ventricular function with standard and speckle-tracking echocardiography and clinical events in adults with D-transposition of the great arteries post atrial switch. J Am Soc Echocardiogr (2011) 0.95

Practice characteristics that influence nonurgent pediatric emergency department utilization. Acad Pediatr (2010) 0.93

Cor triatriatum dexter. Tex Heart Inst J (2007) 0.90

Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant (2008) 0.89

Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation (2016) 0.87

Beyond a broken heart: circulatory dysfunction in the failing Fontan. Pediatr Cardiol (2014) 0.86

Causes and management of drug-induced long QT syndrome. Proc (Bayl Univ Med Cent) (2010) 0.85

Thymidine kinase and mtDNA depletion in human cardiomyopathy: epigenetic and translational evidence for energy starvation. Physiol Genomics (2013) 0.84

Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol (2007) 0.83

Hepatocellular carcinoma in an adult with repaired tetralogy of fallot. Congenit Heart Dis (2012) 0.83

Cyanosis produced by superior vena caval stenosis. Ann Thorac Surg (2008) 0.83

Cardiac resynchronization therapy in adult patients with repaired tetralogy of fallot and left ventricular systolic dysfunction. Pacing Clin Electrophysiol (2013) 0.83

MDCT of thoraco-abdominal trauma: an evaluation of the success and limitations of primary interpretation using multiplanar reformatted images vs axial images. Emerg Radiol (2007) 0.83

Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol (2013) 0.82

Myocardial deformation imaging of the systemic right ventricle by two-dimensional strain echocardiography in patients with d-transposition of the great arteries. Hellenic J Cardiol (2009) 0.82

Risk factors for major adverse events late after Fontan palliation. Congenit Heart Dis (2014) 0.81

Usefulness of cardiac index and peak exercise oxygen consumption for determining priority for cardiac transplantation. Am J Cardiol (2010) 0.81

Unusual origin of type 1 atrioventricular block with comments on Wenckebach's contribution. Proc (Bayl Univ Med Cent) (2011) 0.81

More on hepatocellular carcinoma after the Fontan procedure. N Engl J Med (2013) 0.81

BIOSPIDA: A Relational Database Translator for NCBI. AMIA Annu Symp Proc (2010) 0.80

Pulmonary arterial hypertension in patients with prior atrial switch procedure for d-transposition of great arteries (dTGA). Int J Cardiol (2009) 0.79

Biventricular takotsubo cardiomyopathy: case report and general discussion. Tex Heart Inst J (2013) 0.79

Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery. Pediatr Crit Care Med (2016) 0.78

Left ventricular function improves after pulmonary valve replacement in patients with previous right ventricular outflow tract reconstruction and biventricular dysfunction. Tex Heart Inst J (2011) 0.78

Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol (2007) 0.78

Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy. J Heart Lung Transplant (2005) 0.78

Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation (2016) 0.77

Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. J Heart Lung Transplant (2013) 0.77

Contrast echocardiography for right-sided heart conditions: case reports and literature review. Tex Heart Inst J (2008) 0.77

Impact of spironolactone on endothelial function in patients with single ventricle heart. Congenit Heart Dis (2009) 0.76

Improved systemic saturation after ventricular assist device implantation in a patient with decompensated dextro-transposition of the great arteries after the fontan procedure. Tex Heart Inst J (2015) 0.75

Cardiac sarcoidosis: a clinical entity uncommonly recognized. Tex Heart Inst J (2009) 0.75

Lack of Knowledge and Low Readiness for Healthcare Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. J Pediatr Gastroenterol Nutr (2016) 0.75

Letter by Book et al regarding article, "pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia". Circulation (2009) 0.75

Congenital heart disease in the adult: 2004. Radiol Clin North Am (2004) 0.75

Octopus papillary muscle associated with a left lateral accessory pathway. Congenit Heart Dis (2009) 0.75

Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. J Pediatr Gastroenterol Nutr (2017) 0.75

ECG Quiz. Diffuse ST segment elevation – a diagnostic predicament. J Electrocardiol (2015) 0.75

Exceptional survival: double inlet left ventricle presenting with aortic dissection. Int J Cardiol (2006) 0.75

Adult congenital pulmonary valve replacement: a simple, effective, and reproducible technique. Congenit Heart Dis (2008) 0.75

Right ventricular function in adult patients with Eisenmenger physiology: insights from quantitative echocardiography. Echocardiography (2010) 0.75

Tricuspid valve replacement through a left atriotomy and transseptal approach in a congenitally malformed heart. Congenit Heart Dis (2012) 0.75

Benefits of cardiac resynchronization therapy in outpatients with indicators for heart transplantation. J Heart Lung Transplant (2003) 0.75

Hepatitis B vaccination in heart transplant candidates. J Heart Lung Transplant (2005) 0.75

Percutaneous ventricular assist device in hypertrophic obstructive cardiomyopathy with cardiogenic shock: bridge to myectomy. Ann Thorac Surg (2012) 0.75

Thoracoscopic approach to epicardial lead implantation in adult patients with previous congenital cardiac surgery. Innovations (Phila) (2006) 0.75

Operations research applied to radiotherapy, an NCI-NSF-sponsored workshop February 7-9, 2002. Int J Radiat Oncol Biol Phys (2003) 0.75

Percutaneous interventions in adults with complex cyanotic congenital heart disease. Congenit Heart Dis (2006) 0.75

Twin pregnancy in a woman with pulmonary atresia, ventricular septal defect, and aortopulmonary collaterals complicated by Eisenmenger physiology. Int J Cardiol (2010) 0.75